Conference Call with Torrent Pharmaceuticals Management and Analysts on Q1FY23 Performance and Outlook. Listen to the full earnings transcript.
Torrent Pharmaceuticals announced Q1FY23 results: Revenue at Rs 2,347 crores up by 10%. Gross margins: 72%; EBITDA margins: 32%. EBITDA at Rs. 742 crores was up by 3%. Net profit after tax at Rs. 354 crores was up by 7%. Result PDF